Clinical Trial Update: Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of ERCC1 in Treatment Decision [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adjuvant gemcitabine/cisplatin after surgical resection for pancreatic cancer; the study explored ERCC1 as a biomarker to guide treatme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Neoplasms

Drugs mentioned

• Gemzar (gemcitabine)
• Platinol (cisplatin)

Snippet

Sponsor: Emory University | Conditions: Pancreatic Neoplasms, Pancreatic Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-08-09